Clinical toxicology is a subspecialty of medication concentrating on toxicology and giving the finding, the board, and anticipation of harming and other unfavorable impacts because of meds, word related and ecological toxicants, and organic agents. Medical toxicologists are engaged with the evaluation and treatment of a wide assortment of issues, including intense or interminable harming, unfriendly medication responses (ADRs), tranquilize overdoses, envenomations, substance misuse, mechanical mishaps, and other compound exposures.

Clinical toxicology is authoritatively perceived as a clinical subspecialty by the American Board of Medical Specialties. Its professionals are doctors, whose essential specialization is by and large in crisis medication, word related medication, or pediatrics.

Clinical toxicology is firmly identified with clinical toxicology, with the last control including non-doctors too (for the most part drug specialists or researchers).

Standard pharmaceutical toxicology programs go through a progression of studies with expanding length, at first looking for a most extreme endured portion at that point supporting clinical preliminaries of expanding length until at last an investigation is run that will bolster lifetime organization in people. In most of cases for human clinical preliminaries supporting quality treatment, the treatment is given just a single time, and as a rule, the treatment is expected to be communicated in unendingness—a solitary clinical portion may speak to "lifetime organization." Therefore, the preclinical security program for a quality treatment normally comprises of one mid-to long haul study, in some cases with between time timepoints to help assess the transient idea of potential impacts.